Molecular & Cellular Proteomics
ResearchNaturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease*
Cited by (0)
- *
This work was supported, in whole or in part, by National Institutes of Health Grants DK067638 (to A. S. K.); Grants DK075868, DK078244, DK061525, DK080301, and DK082753 (to B. A. J. and J. N.); and Biotechnology Training Program Predoctoral Fellowship Grant 5T32GM08349 (to D. M. G.). This work was also supported by Eurotransbio Grant ETB-2006-016 to the Urosysteomics consortium (www.urosysteomics.com) (to E. S. and H. M.), Lower Saxony Ministry of Economy Grant 203.19-32329-5-461 (to A. G., E. M. W., and H. M.), and the Joslin Diabetes Center. H. Mischak is founder and co-owner of Mosaiques Diagnostics GmbH, which developed the CE-MS technology and the MosaiquesVisu software. P. Zürbig, M. Dakna, Igor Golovko, and Eric Schiffer are employees of Mosaiques Diagnostics GmbH.
This article contains supplemental Tables I–III and figures showing mass spectra.
- b
Both authors contributed equally to this work.
- d
On behalf of the European Kidney and Urine Proteomics consortium.
- m
Supported by InGenious HyperCare Grant LSHM-CT-2006-037093 and British Heart Foundation Grant RG/02/012.
- q
On behalf of the European Uremic Toxin consortium.
- x
Supported by Federal Ministry of Education and Research Grant NGFN/01GR0807.
- ee
Supported by the Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council Interdisciplinary Research Collaboration in Proteomic Technology (IRColl) Grant Radical Solutions for Researching the Proteome (RASOR) and Wellcome Trust Joint Infrastructure Fund Proteomics Grant 29240.
- oo
Supported by INSERM, the “Direction Régional de la Recherche Clinique” (Centre Hospitalier Universitaire de Toulouse, France) under the Interface program and by the Fondation pour la Recherche Médicale.
Supported by European Union Prevention of Diabetic Complications (PREDICTIONS) Grant LSHM-CT-2005-018733.
- ss
Present address: Dept. of Urology, University of Colorado Comprehensive Cancer Center, Aurora, CO 80045.
- vv
Supported by European Union PREDICTIONS Grant LSHM-CT-2005-018733 and by InGenious HyperCare Grant LSHM-CT- 2006-037093.
- ww
Supported by European Union to Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment (sysKID) Grant HEALTH-F2-2009-241544.